Jeffrey peppercorn MD
@EthicsdoctorP
Followers
554
Following
2K
Media
77
Statuses
663
Oncologist and Bioethicist with interest in health policy and rock n roll. Editor-in-Chief JCO Oncology Practice. Tweets and opinions are my own.
Joined October 2016
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study. Read the full article.
ascopubs.org
PURPOSEPatients with intestinal inflammatory diseases such as ulcerative colitis (UC), Crohn's disease (CD), and microscopic colitis (MC) are excluded from clinical trials with immune checkpoint...
0
2
0
Where Have We Been and Where Are We Going? The State of the Oncologist Workforce in America. Read the full article.
ascopubs.org
PURPOSETo identify geographic areas and populations in the United States likely to experience challenges accessing cancer care.METHODSWe tabulated the number of hematologists and medical oncologists...
0
1
0
This #JCOOP simultaneous publication is being presented now during Rapid Oral Abstract Session B at #ASCOQLTY25 ➡️
‼️ #ASCOQLTY25 simultaneous publication by Budhu, et al: Screened But Still Struggling: Challenges in Delivering Financial Assistance After Positive Financial Toxicity Screens: https://t.co/134bFFIAfP
0
4
15
Emily Mackler, PharmD presented her team’s work on cancer drug repositories (CDRs) and found significant participation with YesTx CDR Network leading to patients receiving over $15.5 million in cancer medication at no cost! https://t.co/w2qgSjC0vV
#ASCOQLTY25
0
2
9
‼️ #ASCOQLTY25 simultaneous publication by Roberts, et al: Racial and Ethnic Diversity of the Oncology Workforce: Projections from 2020 to 2060: https://t.co/dSnALMVfEi
0
4
10
‼️ #ASCOQLTY25 simultaneous publication by Mackler, et al: Transforming Cancer Drug Access: Insights on Utilization and Clinician Satisfaction in a Statewide Cancer Drug Repository Network: https://t.co/kDEBAnsKW6
0
5
11
‼️ #QCS25 simultaneous publication by Henrikson, et al: Financial Navigation for People Newly Diagnosed With Cancer: Primary Outcomes From the CAFÉ Randomized Trial: https://t.co/oTGMTM9Wvb
0
3
5
An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice
ascopubs.org
0
1
3
⏰Discounted access to the 2025 @ASCO Quality Care Symposium is ending soon! Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery. 📆 Early Registration by: Wed, September 3 at 11:59 PM (ET) 👉 https://t.co/DBPIaAFgP0
1
14
24
Longitudinal Associations Between Financial Toxicity and Health-Related Quality of Life for Patients With Cancer. Read the full article.
ascopubs.org
PURPOSEEvaluate the longitudinal relationship between financial toxicity (FT), health-related quality of life (HR-QOL), and psychological distress for patients with cancer.METHODSAdults with cancer...
0
2
15
Calling all oncology trainees & early career faculty who love to write!✍️ Please consider submitting your work to the first ever Narrative Medicine Contest in @JCO_ASCO. Deadline is 8/31/2025. https://t.co/vy1uGSCWL0
6
33
116
Remote Clinical Pharmacist Impact on Reducing Total Cost of Care in Enhancing Oncology Model–Enrolled Oncology Practices. Read full article.
ascopubs.org
PURPOSEThe Enhancing Oncology Model (EOM) is a voluntary, risk-based payment model implemented by the Centers for Medicare & Medicaid Services (CMS) to improve cancer care while reducing the total...
0
4
8
Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management. https://t.co/ZIxY5lWjns
@ASCO @JCO_ASCO @JCOOP_ASCO
#CancerCare #MedEd #MedTwitter
@EthicsdoctorP
1
13
30
🚨 Wow! #ASCO25 @ASCO was absolutely massive! 10 @NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert
6
182
588
Another great #ASCO25 wonderful to see my amazing JCO Oncology Practice colleagues! 📝 Loved Dr. DeMichele’s discussion of SERENA-6 and the incredible CHALLENGE trial of exercise in colon cancer survivors. 🏃♂️ And a chance to hang out for a few hours with my daughter! 🥰
0
0
12
Our oral presentation at #ASCO2025 today: environmental burden isn’t just a health hazard - it’s a cancer risk. Counties with higher pollution burden see more cancer, especially lung cancer. Calls for policy action to address environmental justice. @ONealCancerUAB @azar_mak
0
4
12
It continues to be a great honor to serve on the @JCOOP_ASCO Editorial Board; very proud of the @DrMcClellandLab’s 2024 proton #RadOnc paper ➡️ most downloaded editorial in 2024! Always open for submission, 20 years strong! https://t.co/ovDJFnhv60
#ASCO25
#RepresentationMatters
0
2
10
Thank you and congratulations to @SagarLonialMD and @AparGanti - The amazing Associate Editors of @JCOOP_ASCO now rotating off their responsibilities! It was a privilege to work with them for the past 6 years ! @EthicsdoctorP !
1
6
21
Thematic take on @ASCO breast cancer abstracts: 1. Move 'em up. DB09, ASCENT-04, SERENA-6 are really just trials of using agents earlier in the course of advanced disease. Since all patients with the right tumor subtype will eventually get the agent, the only real question is:
1
28
81
Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring | @JCOOP_ASCO #JCOOP @OncoAlert
https://t.co/c70Ze5BEVm
1
21
61